Meta-analysis of epidermal growth factor polymorphisms and cancer risk: Involving 9,779 cases and 15,932 controls

DNA and Cell Biology

Volumn 31, Issue 4, 2012, Pages 568-574

  Li, Teng Fei ^a   Ren, Ke Wei ^b   Liu, Peng Fei ^a  

^a JIANGYIN PEOPLE S HOSPITAL   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR;

ARTICLE; CANCER LOCALIZATION; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; COLORECTAL CANCER; ESOPHAGUS CARCINOMA; EUROPEAN AMERICAN; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; GLEASON SCORE; HUMAN; LIVER CELL CARCINOMA; META ANALYSIS; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; STOMACH CANCER;

CASE-CONTROL STUDIES; EPIDERMAL GROWTH FACTOR; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; NEOPLASMS; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS;

EID: 84859755859     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2011.1394     Document Type: Article

References (57)

1. Abu Dayyeh, B.K., Yang, M., Fuchs, B.C., Karl, D.L., Yamada, S., Sninsky, J.J., O'Brien, T.R., Dienstag, J.L., Tanabe, K.K., Chung, R.T., and HALT-C Trial Group. (2011). A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma. Gastroenterology 141, 141-149.
2. Almeida, L.O., Custódio, A.C., Santos, M.J., Almeida, J.R., Clara, C.A., Pinto, G.R., Rey, J.A., and Casartelli, C. (2010). The A61G EGF polymorphism is associated with development of extraaxial nervous system tumors but not with overall survival. Cancer Genet Cytogenet 198, 15-21.
3. Amend, K.L., Elder, J.T., Tomsho, L.P., Bonner, J.D., Johnson, T.M., Schwartz, J., Berwick, M., and Gruber, S.B. (2004). EGF gene polymorphism and the risk of incident primary melanoma. Cancer Res 64, 2668-2672.
4. Araújo, A.P., Catarino, R., Ribeiro, R., Pereira, D., Pinto, D., and Medeiros, R. (2011a). Epidermal growth factor genetic variation associated with advanced cervical cancer in younger women. Am J Clin Oncol [Epub ahead of print]; DOI: 1097/COC.0b013e31820dbbf5.
5. Araújo, A.P., Costa, B.M., Pinto-Correia, A.L., Fragoso, M., Ferreira, P., Dinis-Ribeiro, M., Costa, S., Reis, and R.M., Medeiros, R. (2011b). Association between EGF + 61A/G polymorphism and gastric cancer in Caucasians. World J Gastroenterol 17, 488-492.
6. Araújo, A.P., Ribeiro, R., Pereira, D., Pinto, D., Sousa, B., Catarino, R., and Medeiros, R. (2009a). Ovarian cancer and genetic susceptibility: association of A61G polymorphism in the EGF gene. Exp Biol Med (Maywood) 234, 241-245.
7. Araújo, A.P., Ribeiro, R., Pinto, D., Pereira, D., Sousa, B., Mauricio, J., Lopes, C., and Medeiros, R. (2009b). Epidermal growth factor genetic variation, breast cancer risk, and waiting time to onset of disease. DNA Cell Biol 28, 265-269.
8. Bao, G., Wang, M., Guo, S., Han, Y., and Xu, G. (2010). Association between epidermal growth factor + 61G/A polymorphism and glioma risk in a Chinese Han population. J Int Med Res 38, 1645-1652.
9. Bhowmick, D.A., Zhuang, Z., Wait, S.D., and Weil, R.J. (2004). A functional polymorphism in the EGF gene is found with increased frequency in glioblastoma multiforme patients and is associated with more aggressive disease. Cancer Res 64, 1220-1223.
10. Casula, M., Alaibac, M., Pizzichetta, M.A., Bono, R., Ascierto, P.A., Stanganelli, I., Canzanella, S., Palomba, G., Zattra, E., Italian Melanoma Intergroup (IMI), and Palmieri, G. (2009). Role of the EGF + 61A >G polymorphism in melanoma pathogenesis: an experience on a large series of Italian cases and controls. BMC Dermatol 9, 7.
11. Chen, K., Wei, Y., Yang, H., and Li, B. (2011). Epidermal growth factor + 61G/A polymorphism and the risk of hepatocellular carcinoma in a Chinese population. Genet Test Mol Biomarkers 15, 251-255.
12. Chen, Y.F., Qi, P., Ruan, C.P., Wang, H., Xu, X.J., Sun, X.J., Liu, Y., and Gao, C.F. (2009). Relationship between polymorphism of epidermal growth factor 5'UTR variant G61A gene and colorectal in patients in China. Pract J Cancer 24, 551-554.
13. Cheung, W.Y., Zhai, R., Kulke, M.H., Heist, R.S., Asomaning, K., Ma, C., Wang, Z., Su, L., Lanuti, M., Tanabe, K.K., Christiani, D.C., and Liu, G. (2009). Epidermal growth factor A61G gene polymorphism, gastroesophageal reflux disease and esophageal adenocarcinoma risk. Carcinogenesis 30, 1363-1367.
14. Costa, B.M., Ferreira, P., Costa, S., Canedo, P., Oliveira, P., Silva, A., Pardal, F., Suriano, G., Machado, J.C., Lopes, J.M., and Reis, R.M. (2007). Association between functional EGF + 61 polymorphism and glioma risk. Clin Cancer Res 13, 2621-2626.
15. Cui, L., Pan, X.M., Ma, C.F., Shang-Guan, J., Yu, H.B., Chen, G.X., and Wang, J. (2010). Association between epidermal growth factor polymorphism and esophageal squamous cell carcinoma susceptibility. Dig Dis Sci 55, 40-45.
16. Daraei, A., Salehi, R., Salehi, M., Emami, M.H., Janghorbani, M., Mohamadhashem, F., and Tavakoli, H. (2011). Erratum to: effect of rs6983267 polymorphism in the 8q24 region and rs4444903 polymorphism in EGF gene on the risk of sporadic colorectal cancer in Iranian population. Med Oncol [Epub ahead of print]; DOI: 10.1007/s12032-011-9980-2.
17. DerSimonian, R., and Laird, N. (1986). Meta-analysis in clinical trials. Control Clin Trials 7, 177-188.
18. Dong, L.M., Potter, J.D., White, E., Ulrich, C.M., Cardon, L.R., and Peters, U. (2008). Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA 299, 2423-2436.
19. Fisher, D.A., and Lakshmanan, J. (1990). Metabolism and effects of epidermal growth factor and related growth factors in mammals. Endocr Rev 11, 418-442.
20. Gao, L.B., Wei, Y.S., Zhou, B., Wang, Y.Y., Liang, W.B., Li, C., Li, Y., Bai, P., Fang, W.L., Xue, H., and Zhang, L. (2008). No association between epidermal growth factor and epidermal growth factor receptor polymorphisms and nasopharyngeal carcinoma. Cancer Genet Cytogenet 185, 69-73.
21. Goto, Y., Ando, T., Goto, H., and Hamajima, N. (2005). No association between EGF gene polymorphism and gastric cancer. Cancer Epidemiol Biomarkers Prev 14, 2454-2456.
22. Hamai, Y., Matsumura, S., Matsusaki, K., Kitadai, Y., Yoshida, K., Yamaguchi, Y., Imai, K., Nakachi, K., Toge, T., and Yasui, W. (2005). A single nucleotide polymorphism in the 5' untranslated region of the EGF gene is associated with occurrence and malignant progression of gastric cancer. Pathobiology 72, 133-138.
23. Harari, P.M., Allen, G.W., and Bonner, J.A. (2007). Biology of interactions: antiepidermal growth factor receptor agents. J Clin Oncol 25, 4057-4065.
24. Harismendy, O., and Frazer, K.A. (2009). Elucidating the role of 8q24 in colorectal cancer. Nat Genet 41, 868-869.
25. Hirschhorn, J.N., Lohmueller, K., Byrne, E., and Hirschhorn, K. (2002). A comprehensive review of genetic association studies. Genet Med 4, 45-61.
26. James, M.R., Hayward, N.K., Dumenil, T., Montgomery, G.W., Martin, N.G., and Duffy, D.L. (2004). Epidermal growth factor gene (EGF) polymorphism and risk of melanocytic neoplasia. J Invest Dermatol 123, 760-762.
27. Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E., and Forman, D. (2011). Global cancer statistics. CA Cancer J Clin 61, 69-90.
28. Jin, G., Miao, R., Deng, Y., Hu, Z., Zhou, Y., Tan, Y., Wang, J., Hua, Z., Ding, W., Wang, L., Chen, W., Shen, J., Wang, X., Xu, Y., and Shen, H. (2007). Variant genotypes and haplotypes of the epidermal growth factor gene promoter are associated with a decreased risk of gastric cancer in a high-risk Chinese population. Cancer Sci 98, 864-868.
29. Jorissen, R.N., Walker, F., Pouliot, N., Garrett, T.P., Ward, C.W., and Burgess, A.W. (2003). Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res 284, 31-53.
30. Kang, H.G., Choi, J.E., Lee, W.K., Kam, S., Cha, S.I., Kim, C.H., Jung, T.H., and Park, J.Y. (2007a). + 61A >G polymorphism in the EGF gene does not increase the risk of lung cancer. Respirology 12, 902-905.
31. Kang, S., Kim, J.W., Park, N.H., Song, Y.S., Park, S.Y., Kang, S.B., and Lee, H.P. (2007b). Epidermal growth factor 61A/G polymorphism and uterine cervical cancer. Int J Gynecol Cancer 17, 492-496.
32. Lanuti, M., Liu, G., Goodwin, J.M., Zhai, R., Fuchs, B.C., Asomaning, K., Su, L., Nishioka, N.S., Tanabe, K.K., and Christiani, D.C. (2008). A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome. Clin Cancer Res 14, 3216-3222.
33. Li, Y., Xie, Q., Lu, F., Zhao, J., Mao, P., Li, Z., Liu, S., and Zhuang, H. (2010). Association between epidermal growth factor 61A/G polymorphism and hepatocellular carcinoma susceptibility in Chinese patients. Liver Int 30, 112-118.
34. Lim, Y.J., Kim, J.W., Song, J.Y., Hong, M.S., Jin, S.Y., Yoon, S.H., Park, H.J., Choe, B.K., Lee, J.J., Yim, S.V., Hong, S.I., Baik, H.H., Ha, E., and Park, Y.H. (2005). Epidermal growth factor gene polymorphism is different between schizophrenia and lung cancer patients in Korean population. Neurosci Lett 374, 157-160.
35. Limaye, P.B., Bowen, W.C., Orr, A.V., Luo, J., Tseng, G.C., and Michalopoulos, G.K. (2008). Mechanisms of hepatocyte growth factor-mediated and epidermal growth factor-mediated signaling in transdifferentiation of rat hepatocytes to biliary epithelium. Hepatology 47, 1702-1713.
36. Liu, X., Li, L., Chen, X.,Wang, X.,Mu, L., Li, Y., Xu, Q., Xie,Q., and Lu, F. (2009). No association between EGF + 61A/G polymorphismand increased risk of glioma. Int J Biol Markers 24, 77-82.
37. Mantel, N., and Haenszel, W. (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22, 719-748.
38. McCarron, S.L., Bateman, A.C., Theaker, J.M., and Howell, W.M. (2003). EGF + 61 gene polymorphism and susceptibility to and prognostic markers in cutaneous malignant melanoma. Int J Cancer 107, 673-675.
39. Normanno, N., Bianco, C., De Luca, A., and Salomon, D.S. (2001). The role of EGF-related peptides in tumor growth. Front Biosci 6, D685-D707.
40. Normanno, N., De Luca, A., Bianco, C., Strizzi, L., Mancino, M., Maiello, M.R., Carotenuto, A., De Feo, G., Caponigro, F., and Salomon, D.S. (2006). Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 366, 2-16.
41. Pinto, G.R., Yoshioka, F.K., Clara, C.A., Santos, M.J., Almeida, J.R., Burbano, R.R., Rey, J.A., and Casartelli, C. (2009). Association study of an epidermal growth factor gene functional polymorphism with the risk and prognosis of gliomas in Brazil. Int J Biol Markers 24, 277-281.
42. Qi, P., Chen, Y.M., Gao, C.F., Fang, M., Sun, X.J., and Liu, Y. (2008). Relationship between polymorphism of epidermal growth factor 5'UTR variant G61A gene and hepatocellular carcinoma in patients with chronic hepatitis B virus infection in China. Chin J Biol 21, 1051-1053.
43. Qi, P., Wang, H., Chen, Y.M., Sun, X.J., Liu, Y., and Gao, C.F. (2009). No association of EGF 5'UTR variant A61G and hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. Pathology 41, 555-560.
44. Randerson-Moor, J.A., Gaut, R., Turner, F., Whitaker, L., Barrett, J.H., Silva Idos, S., Swerdlow, A., Bishop, D.T., and Bishop, J.A. (2004). The relationship between the epidermal growth factor (EGF) 5'UTR variant A61G and melanoma/nevus susceptibility. J Invest Dermatol 123, 755-759.
45. Shahbazi, M., Pravica, V., Nasreen, N., Fakhoury, H., Fryer, A.A., Strange, R.C., Hutchinson, P.E., Osborne, J.E., Lear, J.T., Smith, A.G., and Hutchinson, I.V. (2002). Association between functional polymorphism in EGF gene and malignant melanoma. Lancet 359, 397-401.
46. Tanabe, K.K., Lemoine, A., Finkelstein, D.M., Kawasaki, H., Fujii, T., Chung, R.T., Lauwers, G.Y., Kulu, Y., Muzikansky, A., Kuruppu, D., Lanuti, M., Goodwin, J.M., Azoulay, D., and Fuchs, B.C. (2008). Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis. JAMA 299, 53-60.
47. Teixeira, A.L., Ribeiro, R., Cardoso, D., Pinto, D., Lobo, F., Fraga, A., Pina, F., Calais-da-Silva, F., and Medeiros, R. (2008). Genetic polymorphism in EGF is associated with prostate cancer aggressiveness and progression-free interval in androgen blockade-treated patients. Clin Cancer Res 14, 3367-3371.
48. Vauleon, E., Auger, N., Benouaich-Amiel, A., Laigle-Donadey, F., Kaloshi, G., Lejeune, J., Delattre, J.Y., Thillet, J., and Sanson, M. (2007). The 61A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastoma. Cancer Genet Cytogenet 172, 33-37.
49. Vishnoi, M., Pandey, S.N., Modi, D.R., Kumar, A., and Mittal, B. (2008). Genetic susceptibility of epidermal growth factor + 61A >G and transforming growth factor beta1-509C > T gene polymorphisms with gallbladder cancer. Hum Immunol 69, 360-367.
50. Wang, S., Zhao, Y., Ruan, Z., Chen, H., Fan, W., Chen, J., Wu, Q., Qian, J., Zhang, T., Huang, Y., and Lu, D. (2010). Association between EGF + 61G/A and glioma risk in a Chinese population. BMC Cancer 10, 221.
51. Wang, Y., Tian, T., Hu, Z., Tang, J., Wang, S., Wang, X., Qin, J., Huo, X., Gao, J., Ke, Q., Jin, G., Ma, H., Wang, X., and Shen, H. (2008). EGF promoter SNPs, plasma EGF levels and risk of breast cancer in Chinese women. Breast Cancer Res Treat 111, 321-327.
52. Wokolorczyk, D., Gliniewicz, B., Sikorski, A., Zlowocka, E., Masojc, B., Debniak, T., Matyjasik, J., Mierzejewski, M., Medrek, K., Oszutowska, D., Suchy, J., Gronwald, J., Teodorczyk, U., Huzarski, T., Byrski, T., Jakubowska, A., Górski, B., van de Wetering, T., Walczak, S., Narod, S.A., Lubinski, J., and Cybulski, C. (2008). A range of cancers is associated with the rs6983267 marker on chromosome 8. Cancer Res 68, 9982-9986.
53. World Health Organization. (2008). The Global Burden of Disease: 2004 Update (World Health Organization, Geneva).
54. Wu, G.Y., Hasenberg, T., Magdeburg, R., Bönninghoff, R., Sturm, J.W., and Keese, M. (2009). Association between EGF, TGF-beta1, VEGF gene polymorphism and colorectal cancer. World J Surg 33, 124-129.
55. Wu, G.Y., Lu, Q., Hasenberg, T., Niedergethmann, M., Post, S., Sturm, J.W., and Keese, M. (2010). Association between EGF, TGF-{beta}1, TNF-{alpha} gene polymorphisms and cancer of the pancreatic head. Anticancer Res 30, 5257-5261.
56. Yuan, J., Yin, C.J., Zhao, H., Qin, C., Zhang, Z.D., and Zhang, W. (2011). The association between the - 61G >A polymorphism in the epidermal growth factor gene and susceptibility to renal clear cell carcinoma. Chin J Exp Surg 28, 108-111.
57. Zintzaras, E. (2010). The generalized odds ratio as a measure of genetic risk effect in the analysis and meta-analysis of association studies. Stat Appl Genet Mol Biol 9, Article21.